Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $12.6 million.

  • Kewaunee Scientific's Cash & Equivalents fell 5149.25% to $12.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $12.6 million, marking a year-over-year decrease of 5149.25%. This contributed to the annual value of $14.9 million for FY2025, which is 3578.03% down from last year.
  • Latest data reveals that Kewaunee Scientific reported Cash & Equivalents of $12.6 million as of Q4 2025, which was down 5149.25% from $19.5 million recorded in Q3 2025.
  • In the past 5 years, Kewaunee Scientific's Cash & Equivalents ranged from a high of $26.0 million in Q4 2024 and a low of $4.4 million during Q2 2022
  • Its 5-year average for Cash & Equivalents is $12.6 million, with a median of $12.6 million in 2023.
  • In the last 5 years, Kewaunee Scientific's Cash & Equivalents skyrocketed by 18806.42% in 2022 and then plummeted by 5564.0% in 2025.
  • Over the past 5 years, Kewaunee Scientific's Cash & Equivalents (Quarter) stood at $4.7 million in 2021, then soared by 99.77% to $9.4 million in 2022, then skyrocketed by 45.68% to $13.7 million in 2023, then surged by 89.21% to $26.0 million in 2024, then plummeted by 51.49% to $12.6 million in 2025.
  • Its last three reported values are $12.6 million in Q4 2025, $19.5 million for Q3 2025, and $14.9 million during Q2 2025.